Showing results (61-70 of 111) with videos related to
Sort By:
Pageof 12
Cancer Biology & Therapy|March 9, 2005
High efficiency transduction of dendritic cells by adenoviral vectors targeted to DC-SIGNNikolay Korokhov, Tanja D de Gruijl, Wayne A Aldrich, et al.Oncotarget|December 19, 2018
Intratumoral CD56bright natural killer cells are associated with improved survival in bladder cancerNeelam Mukherjee, Niannian Ji, Vincent Hurez, et al.Oncoimmunology|November 6, 2018
Adipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast CancerBogang Wu, Xiujie Sun, Harshita B Gupta, et al.Journal for Immunotherapy of Cancer|March 25, 2026
Telmisartan increases olaparib efficacy in homologous recombination proficient tumors by augmenting type I interferon productionClare E Murray, Carlos O Ontiveros, Jordan Wentworth, et al.The Journal of Steroid Biochemistry and Molecular Biology|May 29, 2012
Antiestrogenic activity of flavonoid phytochemicals mediated via the c-Jun N-terminal protein kinase pathway. Cell-type specific regulation of estrogen receptor alphaBridgette M Collins-Burow, James W Antoon, Daniel E Frigo, et al.Autophagy|July 4, 2014
Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumorsDevalingam Mahalingam, Monica Mita, John Sarantopoulos, et al.Cancer Prevention Research (Philadelphia, Pa.)|November 28, 2013
eRapa restores a normal life span in a FAP mouse modelPaul Hasty, Carolina B Livi, Sherry G Dodds, et al.Cancer Research|February 8, 2005
CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancersIlona Kryczek, Andrzej Lange, Peter Mottram, et al.Aging Cell|August 29, 2015
Chronic mTOR inhibition in mice with rapamycin alters T, B, myeloid, and innate lymphoid cells and gut flora and prolongs life of immune-deficient miceVincent Hurez, Vinh Dao, Aijie Liu, et al.Oncoimmunology|August 16, 2019
Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trialNiannian Ji, Neelam Mukherjee, Edwin E Morales, et al.Pageof 12